Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

XOMA Corporation

Tracked across 3 events · 19 articles · First seen Jan 08, 2026 · Last active Jul 14, 2026

Sentiment
23
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 20
Business
Impact: XOMA Corporation announced cash dividends for its Series A and Series B Preferred Stock and will redeem all outstanding shares of Preferred Stock. This action is in connection with its pending merger with Auddia Merger Sub, Inc., a subsidiary of Ligand Pharmaceuticals Incorporated. Additionally, XOMA Corporation set a record date for the distribution of contingent value rights (CVRs) to its common stock holders.
Jun 12, 2026 · 7 articles
3 50
Business
Impact: Acquired by Ligand; shareholders received $39/share plus CVRs; delisted from Nasdaq.
Jul 14, 2026 · 6 articles
2 0
Business
Impact: XOMA Corporation is the proposed acquirer of Generation Bio Co., with Generation Bio shareholders receiving cash and contingent value rights.
Jan 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track XOMA Corporation live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.